XML 28 R7.htm IDEA: XBRL DOCUMENT v3.6.0.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Cash flows from operating activities:    
Consolidated net income (loss) $ 32,041 $ (4,363)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Income from investments in unconsolidated entities (6,219) (5,884)
Provision for loan credit losses 1,659 10,848
Impairment expense 8,077 6,638
Change in fair value of warrants (588) 3,305
Deferred income tax (21,638) 3,273
Loan discount amortization and fee accretion (3,109) (1,778)
Interest income in excess of cash collected (1,063)
Stock-based compensation 363 640
Debt issuance cost amortization 381
Other 16 10
Changes in operating assets and liabilities:    
Accounts receivable (457) (74)
Other assets (396) (648)
Accounts payable and other liabilities (106) (76)
Net cash provided by operating activities 9,643 11,209
Cash flows from investing activities:    
Cash distributions from investments in unconsolidated entity 7,222 6,940
Cash received for settlement of warrants 1,405
Net increase in finance receivables (29,717) (25,849)
Marketable investment principal payment 41 80
Other (3) (50)
Net cash provided by (used in) investing activities (21,052) (18,879)
Cash flows from financing activities:    
Net proceeds from issuance of common stock 17
Cash paid for fractional shares due to reverse split (213)
Distribution to non-controlling interests (3,696) (3,575)
Net cash used in financing activities (3,696) (3,771)
Net increase (decrease) in cash and cash equivalents (15,105) (11,441)
Cash and cash equivalents at beginning of period 47,287 58,728
Cash and cash equivalents at end of period 32,182 47,287
Supplemental noncash flow activity:    
Common stock received in connection with amendment of finance receivable 150
Consideration (notes and preferred stock) received in connection with loan repayment 8,400
Warrants received in conjunction with the origination of finance receivables 4,688
Common stock received in connection with loan repayment $ 5,837